Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Sarcoma 1NET 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 90Head and Neck Neoplasms 71Carcinoma, Non-Small-Cell Lung 31Thyroid Neoplasms 28Melanoma 24Ovarian Neoplasms 23Mouth Neoplasms 21Colorectal Neoplasms 19Oropharyngeal Neoplasms 18Carcinoma, Squamous Cell 16Uterine Cervical Neoplasms 15Carcinoma, Renal Cell 15Breast Neoplasms 15Lung Neoplasms 14Neoplasm Metastasis 13Nasopharyngeal Carcinoma 13Urinary Bladder Neoplasms 12Triple Negative Breast Neoplasms 12Stomach Neoplasms 12Laryngeal Neoplasms 12Sarcoma 11Prostatic Neoplasms 11Carcinoma 11Esophageal Neoplasms 10Endometrial Neoplasms 10Neoplasms 9Pancreatic Neoplasms 8Hypopharyngeal Neoplasms 8Salivary Gland Neoplasms 7Thyroid Cancer, Papillary 6

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thoracic Neoplasms × Head & Neck × 30 days × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡